000 01285 a2200373 4500
005 20250517135040.0
264 0 _c20170828
008 201708s 0 0 ger d
022 _a1439-3999
024 7 _a10.1055/s-0042-121606
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKeserü, M
245 0 0 _a[Vismodegib Therapy for Periocular Basal Cell Carcinoma].
_h[electronic resource]
260 _bKlinische Monatsblatter fur Augenheilkunde
_cJan 2017
300 _a64-69 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnilides
_xadministration & dosage
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCarcinoma, Basal Cell
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aOrbital Neoplasms
_xdrug therapy
650 0 4 _aPyridines
_xadministration & dosage
650 0 4 _aSkin Neoplasms
_xdrug therapy
650 0 4 _aTreatment Outcome
700 1 _aGreen, S
700 1 _aDulz, S
773 0 _tKlinische Monatsblatter fur Augenheilkunde
_gvol. 234
_gno. 1
_gp. 64-69
856 4 0 _uhttps://doi.org/10.1055/s-0042-121606
_zAvailable from publisher's website
999 _c26830949
_d26830949